Gilead Sciences, Inc.
GILD
$138.92
$0.560.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.24B | 9.22B | 8.51B | 8.11B | 6.31B |
| Total Depreciation and Amortization | 2.76B | 2.75B | 2.76B | 2.77B | 2.77B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.61B | 2.46B | 2.70B | 1.65B | 2.71B |
| Change in Net Operating Assets | -1.58B | -3.63B | -3.95B | -2.86B | -1.92B |
| Cash from Operations | 13.55B | 10.81B | 10.02B | 9.67B | 9.87B |
| Capital Expenditure | -609.00M | -576.00M | -563.00M | -505.00M | -499.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -12.09B | -906.00M | -1.07B | -536.00M | -939.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.86B | -1.13B | -3.16B | -2.14B | -2.03B |
| Cash from Investing | -10.84B | -2.61B | -4.79B | -3.18B | -3.47B |
| Total Debt Issued | 4.09B | -- | -- | 3.46B | 3.46B |
| Total Debt Repaid | -2.80B | -2.79B | -1.79B | -1.79B | -1.89B |
| Issuance of Common Stock | 304.00M | 322.00M | 408.00M | 549.00M | 550.00M |
| Repurchase of Common Stock | -1.44B | -1.61B | -1.92B | -2.04B | -1.91B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.07B | -4.03B | -4.00B | -3.98B | -3.96B |
| Other Financing Activities | -729.00M | -444.00M | -440.00M | -424.00M | -369.00M |
| Cash from Financing | -4.65B | -8.56B | -7.75B | -4.22B | -4.11B |
| Foreign Exchange rate Adjustments | -30.00M | 62.00M | 92.00M | 32.00M | 81.00M |
| Miscellaneous Cash Flow Adjustments | -1.00M | 0.00 | -1.00M | -1.00M | -- |
| Net Change in Cash | -1.97B | -298.00M | -2.43B | 2.29B | 2.37B |